Related Experiment Video
Updated: Aug 14, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
518
Long noncoding RNAs: glycolysis regulators in gynaecologic cancers
Nengyuan Lv1,2, Siyi Shen1,2, Qianying Chen1,2
1Department of the Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang Province, People's Republic of China.
Cancer Cell International
|January 13, 2023
Summary
Long noncoding RNAs (lncRNAs) promote glycolysis in common gynecologic cancers like ovarian, cervical, and endometrial cancers. Understanding these lncRNAs offers new research avenues for these diseases.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Ovarian, cervical, and endometrial cancers are leading threats to women's health.
- Glycolysis is a critical metabolic pathway in gynecologic cancers.
- Long noncoding RNAs (lncRNAs) are emerging as key regulators in cancer development.
Purpose of the Study:
- To review the role of lncRNAs in regulating glycolysis within gynecologic cancers.
- To highlight lncRNAs that promote glycolysis in these malignancies.
- To propose future research directions.
Main Methods:
- Literature review of studies investigating lncRNAs and glycolysis in gynecologic cancers.
- Analysis of the functional mechanisms of lncRNAs (e.g., ceRNAs, scaffolds).
- Synthesis of current understanding and identification of research gaps.
Main Results:
- Numerous lncRNAs have been identified that promote glycolysis in ovarian, cervical, and endometrial cancers.
- These lncRNAs exert oncogenic functions by modulating downstream target genes.
- Specific examples of glycolysis-promoting lncRNAs and their mechanisms are discussed.
Conclusions:
- lncRNAs play a significant role in promoting glycolysis, thereby contributing to the progression of gynecologic cancers.
- Targeting glycolysis-related lncRNAs presents a potential therapeutic strategy.
- Further research is warranted to fully elucidate these mechanisms and develop clinical applications.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
01:20Types of RNA
6.0K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.0K
01:46Epigenetic Regulation
31.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K